RPTH Journal: Does Fasting Affect Anticoagulant Therapy? – The Effects Of Fasting During Ramadan
RPTH Journal posted on LinkedIn:
”Does fasting affect anticoagulant therapy? This study investigated the effects of fasting during Ramadan.
Results indicate that fasting may slightly affect vitamin K antagonist (VKA) therapy due to changes in diet and medication timing. This cohort study found modest shifts in anticoagulation intensity and dosing – but no rise in death, bleeding, or clotting events.”
Read the full article here.
Title: Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study
Authors: Eva K Kempers, Qingui Chen, Nienke van Rein, Ferdows Atiq, Roger K Schindhelm, Nynke M Wiersma, Charlotte EA Dronkers, Maarten Beinema, Arina J ten Cate-Hoek, Melchior C Nierman, Alexander DM Stork, Patricia Moriarty, Frederikus A Klok, Suzanne C Cannegieter, Marieke JHA Kruip
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis